Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT02097888
NCT02097888UnknownNot Applicable

Influence of Erythropoietin on Bone Marrow Microenvironment: A Pilot Study

Kantonsspital Baselland Bruderholz1 site in 1 country120 target enrollmentStarted: December 2011Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
120
Locations
1
Primary Endpoint
Difference of EPO level between control groups
Study OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

This will be a prospective observational study. The investigators will compare Erythropoietin (Epo) levels, erythropoiesis, and regulators of erythropoiesis, bone imaging and bone metabolism in healthy volunteers living at different altitudes.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Cross Sectional

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •healthy men and non-pregnant women, ages ≥18-40 years and ≥ 60 years living in the predefined area

Exclusion Criteria

  • •Known bone pathology including osteoporosis, known haematological disease, known renal disease, heart insufficiency, pulmonal disease
  • •pregnancy

Outcomes

Primary Outcomes

Difference of EPO level between control groups

Time Frame: up to 4 years

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Kantonsspital Baselland Bruderholz
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

PD Dr. med. Sandrine Meyer-Monard

PD Dr. med.

Kantonsspital Baselland Bruderholz

Study Sites (1)

Loading locations...

Similar Trials

Unknown
Not Applicable
Studying Erythropoietin Receptor Presence and Function in Human Cancer SpecimensCancer
NCT01827514Tel-Aviv Sourasky Medical Center500
Completed
Not Applicable
Study Investigating the Interactions of Bone and Hematopoiesis in the ElderlyMyelodysplastic Syndromes
NCT02867085Technische Universität Dresden297
Completed
Phase 2
Preliminary Administration of EPO and Markers of Cardiac Ischemia Induced by CPBMyocardial Ischemia
NCT00273767University Hospital, Grenoble50
Completed
Phase 4
Erythropoietin in Hemolytic Uremic SyndromeHemolytic-Uremic SyndromeAnemia
NCT03776851Hospital General de Niños Pedro de Elizalde24
Terminated
Not Applicable
An Observational Study to Predict the Response of Erythropoietin Treatment in Participants With Cancer Related Anemia Receiving ChemotherapyAnemia - Cancer Related
NCT01736215Janssen-Cilag Ltd.,Thailand33
Influence of Erythropoietin on Bone Marrow... | Clinical Trial